Related Experiment Video
Updated: Oct 29, 2025
11:12
In situ Transverse Rectus Abdominis Myocutaneous Flap: A Rat Model of Myocutaneous Ischemia Reperfusion Injury
Published on: June 8, 2013
13.9K
Infrahyoid myocutaneous flap: A systematic review
Kyle Boudreaux1, Payam Entezami1, Ameya A Asarkar1
1Department of Otolaryngology/Head & Neck Surgery, LSU Health Shreveport, Shreveport, LA 71103, United States of America.
American Journal of Otolaryngology
|July 12, 2021
Summary
The infrahyoid myocutaneous flap (IHMCF) is a safe and effective option for head and neck reconstruction, showing a 99% survival rate with rare, minor complications. Further research is needed for precise functional outcome assessment.
Area of Science:
- Head and Neck Surgery
- Reconstructive Surgery
- Oncology
Background:
- The infrahyoid myocutaneous flap (IHMCF) is an anterior neck flap for oral cavity and laryngopharyngeal defect reconstruction.
- Its efficacy and postoperative outcomes are not widely recognized.
Purpose of the Study:
- To systematically review and evaluate the postoperative outcomes and efficacy of the IHMCF.
- Assess complication rates and functional results following IHMCF reconstruction.
Main Methods:
- Comprehensive literature search across PubMed, Biological Abstracts, CINAHL Plus, and Web of Science.
- Independent study selection by two researchers based on relevance, sample size, and English language.
- Inclusion of 28 studies with 1027 IHMCF cases.
Main Results:
- High flap survival rate of 99%.
- Minor complications: total skin necrosis (2.5%) and partial skin necrosis (5.8%).
- Functional outcomes: speech (6.4%) and swallowing (6.5%) issues reported. Studies showed moderate bias.
Conclusions:
- IHMCF is safe and effective for medium-sized head and neck mucosal defects in selected patients.
- Particularly useful for oral cavity reconstruction, though functional outcomes require further assessment.
- Complications are rare; meticulous pre-surgical planning is crucial. More prospective trials are recommended.
